Each year, children from around the country, and from countries around the world, travel to Kennedy Krieger to receive treatment for a rare neurodevelopmental disease. Often, these children are the only people in their community with their specific diagnosis, and their families seek out Kennedy Krieger because of its leadership in rare disease diagnoses and treatments, as well as its world-class research striving for cures.
In this special webinar, join Dr. Brad Schlaggar as he convenes a distinguished panel of Kennedy Krieger neurologists, both pediatric and adult, with expertise in clinical care and research on rare diseases of the developing nervous system, who will discuss recent advances, and innovations on the horizon, in this very dynamic and promising area.
Panelists:
- Dr. Erika Augustine, Associate Chief Science Officer; Director, Clinical Trials Unit
- Dr. Ali Fatemi, Chief Medical Officer; Director, Moser Center for Leukodystrophies
- Dr. Jacqueline Harris, Director, Epigenetics Clinic
- Dr. Doris Leung, Director, Center for Genetic Muscle Disorders
- Dr. Connie Smith-Hicks, Director, Center for Synaptic Disorders
